featured
RAAS Inhibitors and Risk of Covid-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19
N. Engl. J. Med 2020 Jun 18;382(25)2441-2448, HR Reynolds, S Adhikari, C Pulgarin, AB Troxel, E Iturrate, SB Johnson, A Hausvater, JD Newman, JS Berger, S Bangalore, SD Katz, GI Fishman, D Kunichoff, Y Chen, G Ogedegbe, JS HochmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.